Abstract
In this chapter, we describe the history of transplantation, the multiple cell types, and mechanisms that are involved in rejection and tolerance of a transplanted organ, as well as summarize the common and promising new therapeutics used in transplant patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gibson T, Medawar PB (1943) The fate of skin homografts in man. J Anat 77(299–310):294
Medawar PB (1944) The behaviour and fate of skin autografts and skin homografts in rabbits: a report to the War Wounds Committee of the Medical Research Council. J Anat 78:176–199
Medawar PB (1945) A second study of the behaviour and fate of skin homografts in rabbits: a report to the War Wounds Committee of the Medical Research Council. J Anat 79(157–176):154
Billingham RE, Brent L, Medawar PB (1954) Quantitative studies on tissue transplantation immunity. II. The origin, strength and duration of actively and adoptively acquired immunity. Proc R Soc Lond B Biol Sci 143:58–80
Owen RD (1945) Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:400–401
Billingham RE, Brent L, Medawar PB (1953) Actively acquired tolerance of foreign cells. Nature 172:603–606
Mitchison NA (1953) Passive transfer of transplantation immunity. Nature 171:267–268
Hume DM, Merrill JP, Miller BF et al (1955) Experiences with renal homotransplantation in the human: report of nine cases. J Clin Invest 34:327–382
Guild WR, Harrison JH, Merrill JP et al (1955) Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc 67:167–173
Merrill JP, Murray JE, Harrison JH et al (1956) Successful homotransplantation of the human kidney between identical twins. J Am Med Assoc 160:277–282
Merrill JP, Murray JE, Takacs FJ et al (1963) Successful transplantation of kidney from a human cadaver. JAMA 185:347–353
Murray JE, Merrill JP, Harrison JH et al (1963) Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 268:1315–1323
Thiel G, Harder F, Lortscher R et al (1983) Cyclosporin A used alone or in combination with low-dose steroids in cadaveric renal transplantation. Klin Wochenschr 61:991–1000
Egerton M, Scollay R, Shortman K (1990) Kinetics of mature T-cell development in the thymus. Proc Natl Acad Sci U S A 87:2579–2582
Surh CD, Sprent J (1994) T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100–103
Anderson MS, Venanzi ES, Klein L et al (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395–1401
Liston A, Lesage S, Wilson J et al (2003) Aire regulates negative selection of organ-specific T cells. Nat Immunol 4:350–354
Aschenbrenner K, D'Cruz LM, Vollmann EH et al (2007) Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 8:351–358
Mathis D, Benoist C (2009) Aire. Annu Rev Immunol 27:287–312
Consortium F.-G (1997) An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17:399–403
Nagamine K, Peterson P, Scott HS et al (1997) Positional cloning of the APECED gene. Nat Genet 17:393–398
Ahonen P, Myllarniemi S, Sipila I et al (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836
Goverman J, Woods A, Larson L et al (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551–560
Liu GY, Fairchild PJ, Smith RM et al (1995) Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407–415
Bouneaud C, Kourilsky P, Bousso P (2000) Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13:829–840
Bianchi T, Pincus LB, Wurbel MA et al (2009) Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOVA mice. J Immunol 182:4665–4674
Lombardi G, Sidhu S, Batchelor R et al (1994) Anergic T cells as suppressor cells in vitro. Science 264:1587–1589
Hao Z, Hampel B, Yagita H et al (2004) T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med 199:1355–1365
Hildeman D, Jorgensen T, Kappler J et al (2007) Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol 19:516–521
Wells AD, Li XC, Li Y et al (1999) Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 5:1303–1307
Li XC (2010) The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance. Transplantation 90:1043–1047
Hutchinson JA, Riquelme P, Sawitzki B et al (2011) Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol 187:2072–2078
Tiemessen MM, Jagger AL, Evans HG et al (2007) CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 104:19446–19451
Lu L, McCaslin D, Starzl TE et al (1995) Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2−) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539–1545
Fu F, Li Y, Qian S et al (1996) Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86−) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62:659–665
Lutz MB, Suri RM, Niimi M et al (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30:1813–1822
Roelen DL, Schuurhuis DH, van den Boogaardt DE et al (2003) Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76:1608–1615
Sato K, Yamashita N, Yamashita N et al (2003) Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18:367–379
Swiecki M, Colonna M (2010) Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 234:142–162
Ochando JC, Homma C, Yang Y et al (2006) Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 7:652–662
Mazariegos GV, Zahorchak AF, Reyes J et al (2005) Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 5:314–322
Tokita D, Mazariegos GV, Zahorchak AF et al (2008) High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 85:369–377
Pak AS, Wright MA, Matthews JP et al (1995) Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1:95–103
Bronte V, Wang M, Overwijk WW et al (1998) Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J Immunol 161:5313–5320
Dugast AS, Haudebourg T, Coulon F et al (2008) Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 180:7898–7906
Marigo I, Bosio E, Solito S et al (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32:790–802
Garcia MR, Ledgerwood L, Yang Y et al (2010) Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 120:2486–2496
Hock BD, Mackenzie KA, Cross NB et al (2012) Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells. Nephrol Dial Transplant 27:402–410
De Wilde V, Van Rompaey N, Hill M et al (2009) Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 9:2034–2047
Casiraghi F, Azzollini N, Cassis P et al (2008) Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181:3933–3946
English K, Ryan JM, Tobin L et al (2009) Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25 (High) forkhead box P3+ regulatory T cells. Clin Exp Immunol 156:149–160
Wood KJ, Bushell A, Hester J (2012) Regulatory immune cells in transplantation. Nat Rev Immunol 12:417–430
Ding Y, Xu D, Feng G et al (2009) Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes 58:1797–1806
Ge W, Jiang J, Baroja ML et al (2009) Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 9:1760–1772
Shlomchik MJ, Craft JE, Mamula MJ (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 1:147–153
Mauri C (2010) Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol 22:761–767
Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30:221–241
Fillatreau S, Sweenie CH, McGeachy MJ et al (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3:944–950
Mizoguchi A, Mizoguchi E, Takedatsu H et al (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219–230
Mauri C, Gray D, Mushtaq N et al (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197:489–501
Tu W, Lau YL, Zheng J et al (2008) Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 112:2554–2562
Flores-Borja F, Bosma A, Ng D et al (2013) CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 5:173ra123
Newell KA, Asare A, Kirk AD et al (2010) Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120:1836–1847
Heidt S, Hester J, Shankar S et al (2012) B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells. Am J Transplant 12:1784–1792
Taylor PA, Lees CJ, Blazar BR (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493–3499
Wood KJ, Sakaguchi S (2003) Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3:199–210
Sakaguchi S, Miyara M, Costantino CM et al (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10:490–500
Vlad G, Cortesini R, Suciu-Foca N (2008) CD8+ T suppressor cells and the ILT3 master switch. Hum Immunol 69:681–686
Li XL, Menoret S, Bezie S et al (2010) Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J Immunol 185:823–833
Thomson CW, Lee BP, Zhang L (2006) Double-negative regulatory T cells: non-conventional regulators. Immunol Res 35:163–178
Zeng D, Lewis D, Dejbakhsh-Jones S et al (1999) Bone marrow NK1.1(−) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 189:1073–1081
Monteiro M, Almeida CF, Caridade M et al (2010) Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J Immunol 185:2157–2163
Hayday A, Tigelaar R (2003) Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3:233–242
Josefowicz SZ, Rudensky A (2009) Control of regulatory T cell lineage commitment and maintenance. Immunity 30:616–625
Francis RS, Feng G, Tha-In T et al (2011) Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells. Eur J Immunol 41:726–738
Wood KJ, Bushell A, Jones ND (2011) Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells. Immunol Rev 241:119–132
Graca L, Thompson S, Lin CY et al (2002) Both CD4(+)CD25(+) and CD4(+)CD25(−) regulatory cells mediate dominant transplantation tolerance. J Immunol 168:5558–5565
Feng G, Wood KJ, Bushell A (2008) Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation 86:578–589
Hester J, Schiopu A, Nadig SN et al (2012) Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo. Am J Transplant 12:2008–2016
Grohmann U, Orabona C, Fallarino F et al (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3:1097–1101
Kingsley CI, Karim M, Bushell AR et al (2002) CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168:1080–1086
Wing K, Onishi Y, Prieto-Martin P et al (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322:271–275
Siegmund K, Feuerer M, Siewert C et al (2005) Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106:3097–3104
Gandolfo MT, Jang HR, Bagnasco SM et al (2009) Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76:717–729
Graca L, Cobbold SP, Waldmann H (2002) Identification of regulatory T cells in tolerated allografts. J Exp Med 195:1641–1646
Kendal AR, Chen Y, Regateiro FS et al (2011) Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance. J Exp Med 208:2043–2053
Hara M, Kingsley CI, Niimi M et al (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166:3789–3796
Bushell A, Wood K (2007) GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function. Am J Transplant 7:759–768
Issa F, Hester J, Goto R et al (2010) Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 90:1321–1327
Nadig SN, Wieckiewicz J, Wu DC et al (2010) In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 16:809–813
Warnecke G, Bushell A, Nadig SN et al (2007) Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo. Transplantation 83:1459–1465
Liu Z, Tugulea S, Cortesini R et al (1999) Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. Hum Immunol 60:568–574
Trzonkowski P, Zilvetti M, Chapman S et al (2008) Homeostatic repopulation by CD28−CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression. Am J Transplant 8:338–347
Gilliet M, Liu YJ (2002) Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195:695–704
Cai J, Lee J, Jankowska-Gan E et al (2004) Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 199:1017–1023
Zhang ZX, Yang L, Young KJ et al (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 6:782–789
Ford MS, Young KJ, Zhang Z et al (2002) The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 196:261–267
Hill M, Thebault P, Segovia M et al (2011) Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferon-gamma and epstein-barr virus-induced gene 3. Am J Transplant 11:2036–2045
McIver Z, Serio B, Dunbar A et al (2008) Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Br J Haematol 141:170–178
Li Y, Koshiba T, Yoshizawa A et al (2004) Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 4:2118–2125
Martinez-Llordella M, Lozano JJ, Puig-Pey I et al (2008) Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 118:2845–2857
Jukes JP, Wood KJ, Jones ND (2007) Natural killer T cells: a bridge to tolerance or a pathway to rejection? Transplantation 84:679–681
Leveson-Gower DB, Olson JA, Sega EI et al (2011) Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism. Blood 117:3220–3229
Salomon B, Lenschow DJ, Rhee L et al (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440
Tang Q, Henriksen KJ, Boden EK et al (2003) Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol 171:3348–3352
Lenschow DJ, Walunas TL, Bluestone JA (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233–258
Salomon B, Bluestone JA (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19:225–252
Dai Z, Konieczny BT, Baddoura FK et al (1998) Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J Immunol 161:1659–1663
Ozkaynak E, Gao W, Shemmeri N et al (2001) Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2:591–596
Guo L, Li XK, Funeshima N et al (2002) Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS). Transplantation 73:1027–1032
Kosuge H, Suzuki J, Gotoh R et al (2003) Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation 75:1374–1379
Nakamura Y, Yasunami Y, Satoh M et al (2003) Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. Transplantation 75:1115–1118
Nanji SA, Hancock WW, Anderson CC et al (2004) Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant 4:526–536
Guillonneau C, Aubry V, Renaudin K et al (2005) Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation 80:546–554
Harada H, Salama AD, Sho M et al (2003) The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 112:234–243
Fallarino F, Grohmann U, Hwang KW et al (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4:1206–1212
Bour-Jordan H, Esensten JH, Martinez-Llordella M et al (2011) Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol Rev 241:180–205
Fife BT, Guleria I, Gubbels BM et al (2006) Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 203:2737–2747
Ozkaynak E, Wang L, Goodearl A et al (2002) Programmed death-1 targeting can promote allograft survival. J Immunol 169:6546–6553
Cai J, Terasaki PI (2010) Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data. Transplantation 90:1511–1515
Singh N, Pirsch J, Samaniego M (2009) Antibody-mediated rejection: treatment alternatives and outcomes. Transplant Rev (Orlando) 23:34–46
Famulski KS, Broderick G, Einecke G et al (2007) Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 7:2483–2495
Muhlberger I, Perco P, Fechete R et al (2009) Biomarkers in renal transplantation ischemia reperfusion injury. Transplantation 88:S14–S19
Pallet N, Fougeray S, Beaune P et al (2009) Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation. Transplantation 88:605–613
Kim IK, Bedi DS, Denecke C et al (2008) Impact of innate and adaptive immunity on rejection and tolerance. Transplantation 86:889–894
Carvalho-Gaspar M, Billing JS, Spriewald BM et al (2005) Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques. J Immunol Methods 301:41–52
Larsen CP, Morris PJ, Austyn JM (1990) Donor dendritic leukocytes migrate from cardiac allografts into recipients’ spleens. Transplant Proc 22:1943–1944
Hosgood SA, Nicholson ML (2010) The role of perfluorocarbon in organ preservation. Transplantation 89:1169–1175
Moers C, Varnav OC, van Heurn E et al (2010) The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome. Transplantation 90:966–973
Herrera OB, Golshayan D, Tibbott R et al (2004) A novel pathway of alloantigen presentation by dendritic cells. J Immunol 173:4828–4837
Wood KJ, Goto R (2012) Mechanisms of rejection: current perspectives. Transplantation 93:1–10
Anglicheau D, Suthanthiran M (2008) Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation 86:192–199
Terasaki PI, Cai J (2008) Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 86:377–383
Win TS, Pettigrew GJ (2010) Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 90:113–120
Colvin RB, Smith RN (2005) Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5:807–817
Bloom DD, Chang Z, Fechner JH et al (2008) CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. Am J Transplant 8:793–802
Battaglia M, Stabilini A, Migliavacca B et al (2006) Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177:8338–8347
McMurchy AN, Bushell A, Levings MK et al (2011) Moving to tolerance: clinical application of T regulatory cells. Semin Immunol 23:304–313
Sagoo P, Perucha E, Sawitzki B et al (2010) Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 120:1848–1861
Tan J, Wu W, Xu X et al (2012) Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307:1169–1177
Acknowledgments
The work from the authors’ own laboratory described in this review was supported by grants from The Wellcome Trust, Medical Research council, BBSRC, British Heart Foundation, and European Union through the ONE Study, Bio-DrIM and TRIAD projects. The authors would like to thank all members of TRIG past and present for their valuable contributions to the data reviewed herein. The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Stolp, J., Zaitsu, M., Wood, K.J. (2019). Immune Tolerance and Rejection in Organ Transplantation. In: Boyd, A. (eds) Immunological Tolerance. Methods in Molecular Biology, vol 1899. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8938-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8938-6_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8936-2
Online ISBN: 978-1-4939-8938-6
eBook Packages: Springer Protocols